Stewart is the director at Epilepsy Alarms UK, bringing a wealth of experience and expertise to the role. His extensive knowledge of epilepsy alarm systems and their critical importance in improving t... Read More
Introducing NightWatch+, the Clinically Validated Epilepsy Alarm for Nocturnal Seizure Monitoring
We are excited to announce that Epilepsy Alarms UK are bringing the NightWatch+ epilepsy alarm for nocturnal seizure monitoring to the UK market – and is available to order from today.
NightWatch+ is a clinically validated medical device that is designed to monitor epileptic seizures during sleep and alert caregivers, enabling them to provide assistance if needed.
The NightWatch+ is MHRA registered and, notably, bears a Class IIa certification under the EU MDR (2017/745), keeping up with the most up-to-date standards in seizure detection technology.
The MDR certification process demands rigorous clinical evaluation, increased transparency, and robust evidence of safety and performance all of which aim to enhancing patient care and ensuring accountability in the EU medical device market.
Validated by Over 15 Years of Clinical Research
NightWatch+ has successfully met these stringent MDR standards by leveraging over 15 years of collaborative research from leading epilepsy centers SEIN, Kempenhaeghe, and UMC Utrecht, along with multiple long-term prospective trials conducted among both children and adults in diverse living environments.
The extensive data confirms that NightWatch effectively detects the most dangerous nocturnal seizures, significantly reducing the stress of caregivers.
Setting a New Benchmark for the Industry
“We brought NightWatch to the market with a clear mission: to improve the lives of people with epilepsy,” said Jeroen van den Hout, CEO of NightWatch.
“Over the past years, we’ve made a tremendous impact on thousands of families who live with the constant fear of missing a dangerous nighttime seizure. Every night.”
“The hundreds of independent online reviews affirm that we are on the right path. With the launch of NightWatch+, we take our mission even further. Not only does it provide our trusted seizure alarm technology, but it also enables users to track long-term seizure activity via the NightWatch Data Platform. This platform will serve as a foundation for future research, helping us work toward better, more personalized epilepsy care, treatment, and even seizure prediction.”
This milestone underscores the importance of compliant, validated medical solutions in the field of epilepsy care, paving the way forward to drive meaningful innovation and improve patient outcomes.
Available to order from today
The NightWatch+ is available to order from Epilepsy Alarms today, and comes in two models.
About The Author
